| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7dfe6a0b58eafa796df8153e2460c2b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3d3c98c89dcbf5e7ef9f934233f1bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdfcf975092110ad153f8af470345bf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d90a7f8ae83b30efa1b9a8de322d35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5b354b8add9b43784a96a318eaef6d |
| publicationDate |
2008-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1551423-B1 |
| titleOfInvention |
Compositions comprising amphotericin B comprising less than 4 % impurities |
| abstract |
A method for treating fungal infections in a mammal that includes administering a therapeutically effective amount of a composition comprising substantially pure amphotericin B and a pharmaceutically acceptable carrier. Amphotericin BHP is associated with decreased toxicity in mammals and cells measured by cell viability and expression of cytokine markers. Thus, this method allows for reduced adverse reactions when using amphotericin B products. |
| priorityDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |